Shajedul Islam, Frederico O. Gleber-Netto, Collin F. Mulcahy, Mica D. E. Glaun, Snigdha Srivastava, Patrick J. Hunt, Michelle D. Williams, Carly E. Barbon, Michael Spiotto, Weilu Zhao, Adewale Adebayo, Shamima Akhter, Tongxin Xie, Kala Chand Debnath, Hinduja Naidu Sathishkumar, Blake Myers, Sahana Lothumalla, Ismail Yaman, Jared K. Burks, Javier Gomez, Xiayu Rao, Jing Wang, Karin Woodman, Jobran Mansour, Benjamin Arenkiel, Kate L. Osman, Chandler Haxton, Teresa E. Lever, Katherine A. Hutcheson, Moran Amit
{"title":"Neural landscape is associated with functional outcomes in irradiated patients with oropharyngeal squamous cell carcinoma","authors":"Shajedul Islam, Frederico O. Gleber-Netto, Collin F. Mulcahy, Mica D. E. Glaun, Snigdha Srivastava, Patrick J. Hunt, Michelle D. Williams, Carly E. Barbon, Michael Spiotto, Weilu Zhao, Adewale Adebayo, Shamima Akhter, Tongxin Xie, Kala Chand Debnath, Hinduja Naidu Sathishkumar, Blake Myers, Sahana Lothumalla, Ismail Yaman, Jared K. Burks, Javier Gomez, Xiayu Rao, Jing Wang, Karin Woodman, Jobran Mansour, Benjamin Arenkiel, Kate L. Osman, Chandler Haxton, Teresa E. Lever, Katherine A. Hutcheson, Moran Amit","doi":"10.1126/scitranslmed.abq5585","DOIUrl":null,"url":null,"abstract":"<div >The incidence of human papilloma virus–mediated oropharyngeal squamous cell carcinoma (OPSCC) has increased over the past 40 years, particularly among young individuals with a favorable prognosis; however, current therapy often leads to unfortunate side effects, such as dysphagia. Despite the emphasis on dysphagia in previous studies, there is an important research gap in understanding the correlation between neuronal changes and patient-reported and functional outcomes in patients with OPSCC. To address this issue, we examined pathologic tissue samples from patients with OPSCC using multiplex immunofluorescence staining and machine learning to correlate tumor-associated neuronal changes with prospectively collected patient-reported and functional outcomes. We found that tumor enrichment of adrenergic (TH<sup>+</sup>) and CGRP<sup>+</sup> sensory–afferent nerves correlated with poorer swallowing outcomes. Functional electromyography recordings showed correlations between growing (GAP43<sup>+</sup>) and immature cholinergic (ChAT<sup>+</sup>DCX<sup>+</sup>) nerves and denervation patterns in survivors of OPSCC. A murine model of radiation-induced dysphagia further confirmed that immature cholinergic and CGRP<sup>+</sup> nerves were correlated with impaired swallowing. Preclinical interventional studies also supported the independent contributions of CGRP<sup>+</sup> and cholinergic (ChAT<sup>+</sup>) nerves to dysphagia in treated mouse models of OPSCC. Our results suggest that CGRP<sup>+</sup> and ChAT<sup>+</sup> neuronal signaling play distinct roles in tumor- and radiation-induced dysphagia in OPSCC and offer a comprehensive dataset on the neural landscape of OPSCC. These insights may guide early interventions for swallow preservation and the repurposing of neurology-related drugs, such as CGRP blockers, in clinical oncology and survivorship.</div>","PeriodicalId":21580,"journal":{"name":"Science Translational Medicine","volume":"16 758","pages":""},"PeriodicalIF":15.8000,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/scitranslmed.abq5585","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The incidence of human papilloma virus–mediated oropharyngeal squamous cell carcinoma (OPSCC) has increased over the past 40 years, particularly among young individuals with a favorable prognosis; however, current therapy often leads to unfortunate side effects, such as dysphagia. Despite the emphasis on dysphagia in previous studies, there is an important research gap in understanding the correlation between neuronal changes and patient-reported and functional outcomes in patients with OPSCC. To address this issue, we examined pathologic tissue samples from patients with OPSCC using multiplex immunofluorescence staining and machine learning to correlate tumor-associated neuronal changes with prospectively collected patient-reported and functional outcomes. We found that tumor enrichment of adrenergic (TH+) and CGRP+ sensory–afferent nerves correlated with poorer swallowing outcomes. Functional electromyography recordings showed correlations between growing (GAP43+) and immature cholinergic (ChAT+DCX+) nerves and denervation patterns in survivors of OPSCC. A murine model of radiation-induced dysphagia further confirmed that immature cholinergic and CGRP+ nerves were correlated with impaired swallowing. Preclinical interventional studies also supported the independent contributions of CGRP+ and cholinergic (ChAT+) nerves to dysphagia in treated mouse models of OPSCC. Our results suggest that CGRP+ and ChAT+ neuronal signaling play distinct roles in tumor- and radiation-induced dysphagia in OPSCC and offer a comprehensive dataset on the neural landscape of OPSCC. These insights may guide early interventions for swallow preservation and the repurposing of neurology-related drugs, such as CGRP blockers, in clinical oncology and survivorship.
期刊介绍:
Science Translational Medicine is an online journal that focuses on publishing research at the intersection of science, engineering, and medicine. The goal of the journal is to promote human health by providing a platform for researchers from various disciplines to communicate their latest advancements in biomedical, translational, and clinical research.
The journal aims to address the slow translation of scientific knowledge into effective treatments and health measures. It publishes articles that fill the knowledge gaps between preclinical research and medical applications, with a focus on accelerating the translation of knowledge into new ways of preventing, diagnosing, and treating human diseases.
The scope of Science Translational Medicine includes various areas such as cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
The target audience of the journal includes researchers and management in academia, government, and the biotechnology and pharmaceutical industries. It is also relevant to physician scientists, regulators, policy makers, investors, business developers, and funding agencies.